You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

c-Mesenchymal-Epithelial Transition (cMet) Antibody

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced NSCLC Trial in United States (REGN5093-M114)

Recruiting
  • Advanced NSCLC
  • Aurora, Colorado
  • +7 more
Aug 11, 2022

Advanced Solid Tumors Trial in Goyang-si, Seoul (ABN401)

Not yet recruiting
  • Advanced Solid Tumors
  • Goyang-si, Gyeonggi-Do, Korea, Republic of
  • +2 more
Sep 13, 2022

Moesin Expression in Clear Cell Renal Cell Carcinoma

Completed
  • Renal Cell Carcinoma
  • Immunohistochemical detection of Moesin in Clear cell Renal Cell Carcinoma
  • (no location specified)
Sep 20, 2023

Non-Small-Cell Lung Cancer Trial in Worldwide (Amivantamab, Lazertinib, Carboplatin)

Recruiting
  • Non-Small-Cell Lung Cancer
  • Duarte, California
  • +100 more
Jan 31, 2023

Epithelial-Mesenchymal Transition Associated Markers in

Recruiting
  • Peri-implantitis
    • Karbala, Iraq
      Talib A. Alnajaty
    Apr 14, 2023

    Long Non-coding RNA in Process of Epithelial-mesenchymal

    Active, not recruiting
    • Periodontal Disease, AVDC Stage 3and 4
    • +2 more
    • periodontitis challenge
    • Baghdad, Iraq
      saif mohammed T AL Mufti
    Aug 8, 2023

    NSCLC Trial in Worldwide (Capmatinib, Amivantamab)

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Orange, California
    • +40 more
    Aug 3, 2022

    Lung Cancer, Non Small Cell Lung Cancer Trial in Aurora (Amivantamab 1050mg, Amivantamab 1400mg, Amivantamab (to be determined))

    Not yet recruiting
    • Lung Cancer
    • Non Small Cell Lung Cancer
    • Amivantamab 1050mg
    • +2 more
    • Aurora, Colorado
    • +2 more
    Apr 25, 2023

    EMT on CTCs and Disease Progression in Prostate Cancer

    Active, not recruiting
    • Prostate Cancer
    • CellSearch CTC platform
    • Parsortix CTC platform
    • London, Ontario, Canada
      London Regional Cancer Program
    Mar 5, 2022

    Colorectal Tumors Trial in Worldwide (Tepotinib, Cetuximab)

    Active, not recruiting
    • Colorectal Neoplasms
    • Phoenix, Arizona
    • +66 more
    Nov 19, 2021

    NSCLC Trial in Worldwide (Tepotinib, Osimertinib)

    Active, not recruiting
    • Non-small Cell Lung Cancer
    • Yuma, Arizona
    • +178 more
    Dec 19, 2022

    Tumors, Tumor Metastasis, Metastatic Gastrointestinal Carcinoid Tumor Trial in China, United States (EMB-01)

    Recruiting
    • Neoplasms
    • +2 more
    • Canton, Ohio
    • +3 more
    Apr 12, 2022

    Epithelial Mesenchymal Transition and Periodontitis

    Recruiting
    • Periodontitis
    • +5 more
    • Modified Widman flap
    • Gingivectomy
    • Baghdad, Iraq
      College of Dentistry, University of Baghdad
    May 30, 2022

    Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Circulating Tumor Cell Trial in Montpellier (Detection of

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +2 more
    • Detection of circulating tumor cells expressing Axl: CTC-AXL(+)
    • Montpellier, France
      CHU Montpellier
    Jul 1, 2022

    Met Non Small Cell Cancer Registry (MOMENT)

    Recruiting
    • Cancer
      • Fort Lauderdale, Florida
      • +53 more
      Nov 3, 2022

      Bronchiolitis Obliterans Trial (Study morphological and functional of respiratory epithelium)

      Not yet recruiting
      • Bronchiolitis Obliterans
      • Study morphological and functional of respiratory epithelium
      • (no location specified)
      Nov 20, 2023

      Metastatic Triple-Negative Breast Carcinoma Trial in Singapore (Bexarotene, Capecitabine)

      Recruiting
      • Metastatic Triple-Negative Breast Carcinoma
      • Singapore, Singapore
        National Cancer Center Singapore
      Jun 10, 2022

      NSCLC Trial in Japan, Korea, Republic of, Singapore (capmatinib, pemetrexed, cisplatin)

      Terminated
      • Carcinoma, Non-Small-Cell Lung
      • Kashiwa, Chiba, Japan
      • +3 more
      Jan 31, 2023

      Specific Protein Overexpression in Adult Non-Small Cell Lung

      Not yet recruiting
      • Non Small Cell Lung Cancer
        • (no location specified)
        Sep 29, 2023

        NSCLC, NSCLC Stage IV, NSCLC Stage IIIB Trial (MYTX-011)

        Not yet recruiting
        • NSCLC
        • +5 more
        • (no location specified)
        Dec 7, 2022

        Advanced Solid Tumor, Metastatic Colorectal Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Irvine, Chicago, Boston

        Not yet recruiting
        • Advanced Solid Tumor
        • +4 more
        • Irvine, California
        • +2 more
        Nov 27, 2023

        Spread of Colorectal Carcinomatosis

        Completed
        • Peritoneal Carcinomatosis
        • Sampling peritoneal tissue
        • Ghent, Belgium
          Ghent University Hospital
        Dec 9, 2022

        NSCLC, Solid Tumor Trial in Tianjin (HS-20117)

        Not yet recruiting
        • Non-Small Cell Lung Cancer
        • Solid Tumor
        • Tianjin, Tianjin, China
          Tianjin Medical University Cancer Institute and Hospital
        Jul 10, 2023

        Triple Negative Breast Cancer, Chemo Effect, Simvastatin Adverse Reaction Trial in Jakarta Pusat (Simvastatin 40mg, Placebo)

        Recruiting
        • Triple Negative Breast Cancer
        • +2 more
        • Simvastatin 40mg
        • Placebo
        • Jakarta Pusat, DKI Jakarta, Indonesia
          Dr. Cipto Mangunkusumo National Central General Hospital
        Sep 22, 2022

        Unveiling the Microbial Impact on Intestinal Fibrosis

        Not yet recruiting
        • Crohn Disease
        • Surgical specimens of CD and no-IBD patients
        • Milan, Italy
          IRCCS Ospedale San Raffaele
        Oct 2, 2023